Resultados de procura - Francois X. Claret

Limitar resultados
  1. 1
    Phosphatases: The New Brakes for Cancer Development?

    Phosphatases: The New Brakes for Cancer Development? por Qingxiu Zhang, Francois X. Claret

    Publicado 2011
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Targeting Jab1/CSN5 in nasopharyngeal carcinoma

    Targeting Jab1/CSN5 in nasopharyngeal carcinoma por Yunbao Pan, Francois X. Claret

    Publicado 2012
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Trastuzumab: Updated Mechanisms of Action and Resistance in Breast Cancer

    Trastuzumab: Updated Mechanisms of Action and Resistance in Breast Cancer por Thuy Vu, François X. Claret

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    JAB1/CSN5: a new player in cell cycle control and cancer

    JAB1/CSN5: a new player in cell cycle control and cancer por Terry J. Shackleford, François X. Claret

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Emerging roles of Jab1/CSN5 in DNA damage response, DNA repair, and cancer

    Emerging roles of Jab1/CSN5 in DNA damage response, DNA repair, and cancer por Yunbao Pan, Huiling Yang, François X. Claret

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  6. 6
    Novel roles of reactive oxygen species in the pathogenesis of acute myeloid leukemia

    Novel roles of reactive oxygen species in the pathogenesis of acute myeloid leukemia por Fuling Zhou, Qiang Shen, François X. Claret

    Publicado 2013
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  7. 7
    Mutual regulation of microRNAs and DNA methylation in human cancers

    Mutual regulation of microRNAs and DNA methylation in human cancers por Sumei Wang, Wanyin Wu, François X. Claret

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  8. 8
    Personalized drug combinations to overcome trastuzumab resistance in HER2-positive breast cancer

    Personalized drug combinations to overcome trastuzumab resistance in HER2-positive breast cancer por Thuy Vu, Mark X. Sliwkowski, Francois X. Claret

    Publicado 2014
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  9. 9
    Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation.

    Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. por M. Cavigelli, Fabrizio Dolfi, Francois X. Claret, Michael Karin

    Publicado 1995
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Stat3 Inhibitor Stattic Exhibits Potent Antitumor Activity and Induces Chemo- and Radio-Sensitivity in Nasopharyngeal Carcinoma

    Stat3 Inhibitor Stattic Exhibits Potent Antitumor Activity and Induces Chemo- and Radio-Sensitivity in Nasopharyngeal Carcinoma por Yunbao Pan, Fuling Zhou, Ronghua Zhang, François X. Claret

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Dickkopf-1 is a key regulator of myeloma bone disease: Opportunities and challenges for therapeutic intervention

    Dickkopf-1 is a key regulator of myeloma bone disease: Opportunities and challenges for therapeutic intervention por Fuling Zhou, Shan Meng, Huanjin Song, François X. Claret

    Publicado 2013
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  12. 12
    Involvement of microRNA-24 and DNA Methylation in Resistance of Nasopharyngeal Carcinoma to Ionizing Radiation

    Involvement of microRNA-24 and DNA Methylation in Resistance of Nasopharyngeal Carcinoma to Ionizing Radiation por Sumei Wang, Rong Zhang, François X. Claret, Huiling Yang

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer

    Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer por Guohong Liu, François X. Claret, Fuling Zhou, Yunbao Pan

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  14. 14
    AP-1 Transcription Factors as Regulators of Immune Responses in Cancer

    AP-1 Transcription Factors as Regulators of Immune Responses in Cancer por Vassilios Atsaves, Vasiliki Leventaki, George Z. Rassidakis, Francois X. Claret

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  15. 15
    Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways

    Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways por Yunbao Pan, Q. Zhang, Vassilios Atsaves, Huiling Yang, François X. Claret

    Publicado 2012
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    A nucleosome-dependent static loop potentiates estrogen-regulated transcription from the Xenopus vitellogenin B1 promoter in vitro.

    A nucleosome-dependent static loop potentiates estrogen-regulated transcription from the Xenopus vitellogenin B1 promoter in vitro. por Christopher-Johannes Schild, Francois X. Claret, Walter Wahli, Alan P. Wolffe

    Publicado 1993
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Jab1/CSN5 Negatively Regulates p27 and Plays a Role in the Pathogenesis of Nasopharyngeal Carcinoma

    Jab1/CSN5 Negatively Regulates p27 and Plays a Role in the Pathogenesis of Nasopharyngeal Carcinoma por Yunbao Pan, Qingxiu Zhang, Ling Tian, Xin Wang, Xiaohang Fan, Huizhong Zhang, Francois X. Claret, Huiling Yang

    Publicado 2012
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    All-<i>trans</i>-Retinoic Acid Inhibits Jun N-Terminal Kinase by Increasing Dual-Specificity Phosphatase Activity

    All-<i>trans</i>-Retinoic Acid Inhibits Jun N-Terminal Kinase by Increasing Dual-Specificity Phosphatase Activity por Ho‐Young Lee, Naoko Sueoka, Waun-Ki Hong, David J. Mangelsdorf, François X. Claret, Jonathan M. Kurie

    Publicado 1999
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma

    NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma por Vasiliki Leventaki, Ηλίας Δράκος, L. Jeffrey Medeiros, Megan S. Lim, Kojo S.J. Elenitoba‐Johnson, François X. Claret, George Z. Rassidakis

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Insights into the regulation of the human COP9 signalosome catalytic subunit, CSN5/Jab1

    Insights into the regulation of the human COP9 signalosome catalytic subunit, CSN5/Jab1 por Aude Echalier, Yunbao Pan, Melissa Birol, Nicolas Tavernier, Lionel Pintard, François Hoh, Christine Ebel, Nathalie Galophe, François X. Claret, Christian Dumas

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: